Can You Take Ozempic to Lose Weight? A Comprehensive Look at Its Role in Weight Management

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic and Wegovy, has transformed weight loss treatment for millions of patients worldwide. The medication functions as a glucagon-like peptide-1 receptor agonist, signaling your brain to reduce appetite and increase feelings of fullness. PlexusDx brings this proven therapy directly to patients through licensed compounding, making precision weight management more accessible.

How Semaglutide Works for Weight Loss

Semaglutide mimics the natural hormone GLP-1, which regulates hunger signals in your hypothalamus and slows gastric emptying. When you take semaglutide, your body experiences reduced appetite, stronger satiety between meals, and improved blood sugar control. These combined effects create a sustained caloric deficit without requiring extreme dietary restriction, allowing weight loss to occur more naturally and sustainably.

The medication also influences gut hormones that communicate fullness to your brain, reducing the amount of food needed to feel satisfied. Clinical data shows that patients on semaglutide consume approximately 20–30% fewer calories than baseline without consciously following restrictive diets. This mechanism distinguishes semaglutide from older weight loss drugs that relied solely on stimulation, making it both more tolerable and more effective for long-term results.

Clinical Evidence: What Research Shows About Weight Reduction

The STEP trials, conducted between 2019 and 2021, demonstrated that semaglutide produces clinically significant weight loss across diverse patient populations. Patients receiving the 2.4 mg weekly dose achieved an average weight loss of 15.3% of baseline body weight over 68 weeks, compared to 2.6% in the placebo group. These results held true for patients with pre-diabetes, type 2 diabetes, and those without diabetes, establishing semaglutide as a broadly effective intervention.

Importantly, weight loss benefits appeared within 4–8 weeks of starting treatment, with most of the loss occurring in the first 6 months, then stabilizing as the body reaches a new equilibrium. Patients who discontinued semaglutide typically regained weight within 6–12 months, indicating that sustained dosing is necessary to maintain results. PlexusDx supports ongoing treatment with flexible commitment options, ensuring you can maintain your progress without gaps in medication supply.

Semaglutide Versus Other GLP-1 Therapies: Understanding Your Options

While Ozempic and Wegovy contain semaglutide, tirzepatide (in Zepbound and Mounjaro) represents a different class called dual GLP-1/GIP receptor agonists, offering additional hormonal pathways for weight reduction. Tirzepatide produced weight loss of 20–22% in SURMOUNT trials, approximately 5 percentage points higher than semaglutide alone. PlexusDx offers both compounded semaglutide injections starting at $149/month and compounded tirzepatide injections starting at $249/month, allowing your provider to match the medication to your genetics and response profile.

Oral formulations of both medications are also available through PlexusDx—oral semaglutide at $249/month and oral tirzepatide at $279/month—for patients who prefer not to self-inject. Some patients benefit from PlexusDx's Microdose GLP-1 Protocol ($129/month flat) to minimize side effects while building tolerance, or from GLP-Squared combinations that layer both compounds for enhanced response. Your prescriber will recommend the formulation and medication class best suited to your weight loss goals, genetic predispositions, and lifestyle.

Access Without Insurance: How PlexusDx Makes Semaglutide Affordable

Traditional Ozempic and Wegovy prescriptions often require insurance or significant out-of-pocket costs, leaving many patients unable to access this life-changing therapy. PlexusDx compounded semaglutide injections begin at $149/month, with no insurance requirement, no membership fees, and eligibility for HSA/FSA accounts. This pricing structure reflects PlexusDx's commitment to making precision weight loss medicine available to patients across all 50 states, regardless of insurance status.

PlexusDx partners exclusively with licensed 503A compounding pharmacies to prepare all medications, ensuring quality, sterility, and accuracy matching pharmaceutical-grade standards. After your first month of treatment, you have the option to add the Precision Peptide Genetic Test ($99), which maps 14 weight-regulation pathways and 49 peptides to identify your unique genetic predispositions at markers like GLP1R rs6923761 and MC4R rs17782313. This personalization helps your provider optimize your medication choice and dosing strategy for maximum results.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Ozempic actually prescribed for weight loss, or is it only for diabetes?

Ozempic is FDA-approved for type 2 diabetes, but Wegovy—the branded semaglutide product—is FDA-approved specifically for weight management. Many physicians prescribe Ozempic off-label for weight loss due to its proven efficacy, and compounded semaglutide from licensed 503A pharmacies delivers the same active ingredient. PlexusDx compounded semaglutide injections provide this therapy without insurance, starting at $149/month.

How much weight can I expect to lose with semaglutide?

Clinical trials show average weight loss of 15% of baseline body weight over 68 weeks with the 2.4 mg weekly dose, though individual results range from 5% to 25% depending on genetics, diet, exercise, and adherence. Weight loss typically accelerates in the first 3–4 months, then reaches a plateau as your body adapts. PlexusDx's optional Precision Peptide Genetic Test identifies your GLP1R and GIPR genetic variants to help predict your likely response range.

Can I afford semaglutide if I don't have insurance?

Yes. PlexusDx compounded semaglutide injections start at $149/month with no insurance needed, no membership fees, and HSA/FSA eligibility. All three commitment tiers maintain flat pricing regardless of dose, so your price will not increase if your dose needs adjustment. This pricing makes precision weight loss accessible across all 50 states.

What are the most common side effects, and how long do they last?

Nausea, constipation, and loss of appetite are the most frequently reported side effects, typically mild and transient when dosing begins low. Most patients experience side effect resolution within 2–4 weeks as their body adapts. PlexusDx's Microdose GLP-1 Protocol ($129/month) offers slower dose escalation to minimize discomfort while building tolerance, making treatment more comfortable for sensitive patients.

How does the Precision Peptide Genetic Test help personalize my semaglutide therapy?

PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes 150+ genetic insights across 49 weight-regulating peptides and 14 pathways, including GLP1R, GIPR, FTO, and MC4R variants. Patients with certain GLP1R or GIPR variants may show stronger responses to semaglutide, while others may benefit more from tirzepatide or combination therapy. This data allows your provider to match your medication and dose to your genetic profile, maximizing efficacy and minimizing trial-and-error.

Related Reading

• Effects Of Adrb3 Rs4994 On Weightobesity Role Of Genetic Info In Weight Management
• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.